Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal Jurnal Pharma Bhakta
Sugeng Walujo, Djembor
Unknown Affiliation
Health Professions Medicine & Pharmacology

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
THE MINIMALIST ANALYSIS OF THE COST OF USING CEFIXIME AND METRONIDAZOLE ANTIBIOTICS IN BPJS CLASS III PATIENTS WITH CHILD ACUTE DIARRHEA IN THE INPATIENT CARE INSTALLATION OF RSM AHMAD DAHLAN, KEDIRI CITY (JANUARY – JUNE PERIOD) IN 2023 Sugeng Walujo, Djembor; Ayu Sagita, Fivo
JURNAL PHARMA BHAKTA Vol 5 No 1 (2025): Mei 2025
Publisher : FACULTY OF PHARMACY, INSTITUT ILMU KESEHATAN BHAKTI WIYATA

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56710/jpb.v5i1.126

Abstract

Diarrhea is a disease caused by bacterial infection characterized by nausea, vomiting, abdominal pain, headache, fever, chills, and discomfort. The choice of antibiotics for the treatment of diarrhea is based on the severity, location of the infection, and type of infecting microorganism. The purpose of the study was to determine the minimum cost of antibiotic use in BPJS class III patients with acute diarrhea in the inpatient installation of RSM Ahmad Dahlan Kediri City from January to June 2023. This study was an observational analytic study with a cross-sectional research design through a retrospective approach. Then the data were analyzed using SPSS, using the Mann Whitney test analysis method. The results showed that metronidazole antibiotics were more cost minimization than cefixime antibiotics with an average of Rp3,663,288 and Rp4,295,103, respectively. Based on the results of the statistical test, the p value was 0.294> 0.05, so it can be interpreted that the amount of direct medical costs between patients using cefixime antibiotic therapy and metronidazole antibiotics did not differ significantly.
ANALISIS EFEKTIVITAS BIAYA ANTIBIOTIK LEVOFLOXACIN DAN CEFIXIME PADA PASIEN PNEUMONIA RAWAT INAP DI RSM AHMAD DAHLAN KEDIRI TAHUN 2022 Sugeng Walujo, Djembor; Juwita, Nanda
JURNAL PHARMA BHAKTA Vol 3 No 2 (2023): November 2023
Publisher : FACULTY OF PHARMACY, INSTITUT ILMU KESEHATAN BHAKTI WIYATA

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Pneumonia adalah infeksi akut yang mengenai jaringan paru-paru (alveoli) yang dapat disebabkan oleh berbagai mikroorganisme seperti virus, jamur dan bakteri. Antibiotik merupakan terapi utama pada penderita pneumonia, antibiotik yang digunakan pada penelitian ini yaitu levofloxacin dan cefixime. Analisis efektivitas biaya merupakan metode farmakoekonomi untuk memilih dan menilai program atau obat yang terbaik pada beberapa pilihan terapi dengan tujuan yang sama. Oleh sebab itu, dilakukan penelitian dengan tujuan melihat efektivitas biaya terapi antibiotik levofloxacin dan cefixime serta jumlah biaya yang dikeluarkan pasien pneumonia selama menjalani rawat inap di RSM Ahmad Dahlan Kediri. ACER suatu obat dari kedua obat yang dibandingkan adalah yang paling rendah dari obat yang dibandingkan. Penelitian ini menggunakan metode penelitian deskriptif dengan pengambilan data secara retrospektif. Sampel pada penelitian ini terdiri dari 30 sampel data rekam medik pasien, 15 pasien (50%) menggunakan terapi levofloxacin dan 15 pasien (50%) menggunakan terapi cefixime. Hasil penelitian menunjukkan, rata-rata biaya penggunaan antibotik levofloxacin sebesar Rp. 3.047.381 per pasien dan cefixime sebesar Rp. 3.149.411 per pasien. Terapi antibiotik pada pneumonia yang paling cost effective berdasarkan nilai ACER adalah antibiotik levofloxacin dengan nilai sebesar Rp 30.474 per pasien.
HUBUNGAN KUALITAS PELAYANAN KEFARMASIAN TERHADAP KEPUASAN PASIEN DI PUSKESMAS NGANTRU KABUPATEN TULUNGAGUNG TAHUN 2025 Sugeng Walujo, Djembor
JURNAL PHARMA BHAKTA Vol 5 No 2 (2025): November 2025
Publisher : FACULTY OF PHARMACY, INSTITUT ILMU KESEHATAN BHAKTI WIYATA

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: High-quality, optimal health services are essential for community well-being. Pharmaceutical service standards guide pharmacy staff in delivering these services, minimizing the risk of medication errors. Objective: A 2025 study aimed to explore the correlation between the quality of pharmaceutical services and patient satisfaction at the Ngantru Regency Tulungagung Public Health Center. Methods: The study employed an analytical observational method with a cross-sectional design. Ninety-seven patients from the health center, meeting specific inclusion and exclusion criteria, were selected using purposive sampling. Data were collected via questionnaires, with the quality of pharmaceutical services as the independent variable and patient satisfaction as the dependent variable. Chi-square tests were used for data analysis. Result: The results indicated that 80.4% of respondents rated the pharmaceutical services as very good, while 19.6% rated them as good. Additionally, 69.1% of respondents reported being very satisfied with the services, and 30.9% reported being satisfied. The chi-square test revealed a statistically significant relationship (p < 0.05) between the quality of pharmaceutical services and patient satisfaction at the Ngantru Health Center. Conclusions: The results of this study can be described that maximum efforts in pharmaceutical services at Ngantru Health Center provide support for community satisfaction in health services. This effort is to provide assurance that pharmaceutical services are carried out optimally so that patients get the best service in the health sector.
Co-Authors Ayu Sagita, Fivo juwita, Nanda